Homeostatic plasticity is thought to play an important role in maintaining the stability of neuronal circuits. During one form of homeostatic plasticity, referred to as synaptic scaling, activity blockade leads to a compensatory increase in synaptic transmission by stimulating in dendrites the local translation and synaptic insertion of the AMPA receptor subunit GluR1. We have previously shown that all-trans retinoic acid (RA) mediates activity blockadeinduced synaptic scaling by activating dendritic GluR1 synthesis and that this process requires RAR␣, a member of the nuclear RA receptor family. This result raised the question of where RAR␣ is localized in dendrites and whether its localization is regulated by RA and/or activity blockade. Here, we show that activity blockade or RA treatment in neurons enhances the concentration of RAR␣ in the dendritic RNA granules and activates local GluR1 synthesis in these RNA granules. Importantly, the same RNA granules that contain RAR␣ also exhibit an accumulation of GluR1 protein but with a much slower time course than that of RAR␣, suggesting that the former regulates the latter. Taken together, our results provide a direct link between dendritically localized RAR␣ and local GluR1 synthesis in RNA granules during RA-mediated synaptic signaling in homeostatic synaptic plasticity.
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FMRP ͉ GluR1 ͉ local protein translation ͉ synaptic scaling H omeostatic synaptic plasticity plays important roles in maintaining the stability of neural networks through the adjustment of global synaptic strength (1, 2) . A particular form of homeostatic plasticity, referred to as synaptic scaling, modifies all synapses onto a neuron concurrently in a multiplicative fashion, with greater synaptic adjustment at stronger synapses than at weaker ones, allowing global changes of synaptic activity while preserving relative synaptic strength between individual synapses (3, 4) . One well characterized form of synaptic scaling is the increase in synaptic strength induced by chronic blockade of neuronal activity with tetradotoxin (TTX) and the NMDA receptor antagonist APV. This form of synaptic scaling, manifested by an increase in synaptic glutamate receptor response, is mediated by the local synthesis and synaptic insertion of homomeric GluR1 receptors (5-7).
We recently found that all-trans retinoic acid (RA), the active form of retinoids in the brain, mediates activity blockade-induced synaptic scaling (8) . We demonstrated that activity blockadewhich induces homeostatic plasticity-strongly stimulates neuronal RA synthesis, which in turn activates dendritic GluR1 synthesis. We thus described a function of RA as a synaptic signal that operates during homeostatic plasticity to up-regulate synaptic strength by increasing the size of the postsynaptic glutamate receptor response. Additionally, we suggested that RAR␣ may be critically involved in this form of RA signaling because RAR␣ is present in dendrites, and knocking down RAR␣ blocks synaptic scaling. These results were surprising, given our previous understanding of the function of RAR␣ in transcription, and raised a number of questions. Where in the dendrites is RAR␣ localized? Is its localization regulated? How does RA act on the localization of RAR␣, and how does this relate to the activation of GluR1 synthesis?
The actions of retinoids are primarily mediated by nuclear receptor proteins termed retinoic acid receptors (RAR-␣, -␤, -␥) and retinoid ''X'' receptors (RXR-␣, -␤, -␥). Like other members of the steroid receptor family, RAR and RXR are well known transcription factors. Although structurally similar, the ligand specificity differs between RAR and RXR in that RAR binds RA with high affinity, whereas RXR binds 9-cis-retinoic acid exclusively (9) . Because 9-cis-RA is undetectable in vivo, the effects of retinoids on gene transcription are presumed to be mediated largely by RA interactions with RARs (10). In the mammalian brain, RARs exhibit distinct patterns of expression. Specifically, RAR␣ is found in the cortex and hippocampus (11, 12) , whereas RAR␤ is highly expressed in the caudate/putamen, nucleus accumbens, and olfactory tubercles (11, 12) . RAR␥ is not detectable in the CNS (11) (but see ref. 12 ).
In the current study, we examined at the ultrastructural level the dynamic regulation of RAR␣ localization by RA or activity blockade. Consistent with the transcription-independent action of RA during synaptic scaling (8), we found that RAR␣ is present in neuronal dendrites in addition to its well accepted presence in the nucleus. In the dendrites, RAR␣ is absent from RNA granules at basal conditions. RA treatment or activity blockade, however, stimulate rapid accumulation of RAR␣ in RNA granules, where GluR1 synthesis is subsequently activated. These results suggest that the induction of local GluR1 synthesis in dendrites is associated with a RA-regulated change in the localization of RAR␣.
Results

RA Induces Local Translation in Neuronal Dendrites of a Reporter
mRNA Containing the GluR1 UTRs. Dendritic targeting and translation of mRNAs are believed to be mediated by cis-regulatory elements in the 5Ј and 3Ј flanking the ORF. To examine whether GluR1 UTRs mediate RA-dependent translation control, we generated a reporter construct in which an ORF encoding a membrane-anchored GFP (Tac-GFP) is flanked by the 5Ј and 3Ј UTRs of the GluR1 mRNA (Fig. 1A) . In hippocampal neurons transfected with this reporter construct, the Tac-GFP mRNA was targeted to dendrites (Fig. 1B) . Twenty-four hours after transfection, GFP expression could be detected in the soma and dendrites. Although the GFP signal in the soma was usually saturated, the signal in dendrites showed discrete stationary ''hotspots'' on top of a diffuse background (Fig. 1C) . We photobleached a 70 ϫ 70-m area covering the region of interest (boxed area in Fig. 1C ) and its surround, and treated the cultured neuron with RA or DMSO. A marked increase in newly synthesized GFP in the dendritic hotspots was observed 30-60 min after RA treatment, whereas the recovery of diffuse background signal within this time frame was minimal (Fig. 1D) . Consistent with the notion of local protein synthesis, this increase in newly synthesized GFP in the dendritic hotspots was sensitive to the translation inhibitor anisomycin but not to the transcription inhibitor actinomycin D (Fig. 1 C and D) . The differences in the recovery of GFP signal at the hotspots are not due to treatment-related differences in protein diffusion because treated and untreated neurons exhibited a similar increase in GFP signal in dendritic regions outside of the hotspots (RA: 144.3 Ϯ 11.4%, n ϭ 13; RA plus ActD: 157.9 Ϯ 20%, n ϭ 18; RA plus anis: 166.9 Ϯ 9.7%, n ϭ 16; P Ͼ 0.1).
A recent study reported an effect of RA on spine morphogenesis in hippocampal neurons that requires translation of GluR1 protein through activation of mTOR signaling (13) . We therefore examined the effect of the mTOR inhibitor rapamycin on RA-induced GluR1 synthesis in synaptoneurosomes prepared from rat hippocampus. Consistent with the effect we reported previously (8), 1 M RA induced rapid synthesis of GluR1. However, addition of rapamycin 30 min before the RA treatment did not block RA-induced GluR1 synthesis ( Fig. 2) , indicating that mTOR-dependent signaling is not required for the RA-induced activation of GluR1 translation in neuronal dendrites.
Dendritic GluR1 Synthesis in Neuronal RNA Granules. Local protein synthesis in dendrites requires mRNA and the translation machinery, both of which are trafficked into dendrites in RNA granules, which are large RNA-protein complexes that serve not only as mRNA trafficking units but also as local storage compartments for mRNAs and the translation machinery (14, 15) . The presence of the 30S and 50S ribosomal subunits, but the lack of certain translation factors, in RNA granules (14, 15) suggests that these mRNA storage sites can be translationally activated upon recruitment of these translation factors. To investigate the possible role of RA in protein translation in RNA granules, we performed standard and ImmunoGold EM studies on cultured neurons and examined the local- ization of RAR␣ and GluR1 as a function of RA treatment or synaptic activity blockade.
Consistent with previous findings (16), we found in our cultured hippocampal neurons polyribosomes in dendrites where they are sometimes near the synapse (Fig. 3A, arrows) . Electron-dense (dark) complexes without a clearly defined membranous boundary (Fig. 3A, asterisk) were occasionally associated with the polyribosomes, possibly representing RNA granules. FMRP (fragile-X mental retardation protein), a known marker for RNA granules, is highly and specifically enriched in these dark complexes, as shown by ImmunoGold labeling using an FMRP antibody (Fig. 3B) . The average number of FMRP gold particles found inside each electrondense granule was 26.3 Ϯ 5.2, whereas only 1.7 Ϯ 0.3 particles were observed in similar-sized dendritic regions outside the granules (n ϭ 20 RNA granules). To show that these FMRP-containing structures are translationally competent, we examined the presence of critical translation factors such as ribosomal protein S6 and eIF4E (eukaryotic initiation factor 4E), which initiates capdependent protein translation. Consistent with previous reports (15), S6 is found in RNA granules at basal conditions ( Fig. 3 C1 and  C2 ). eIF4E was shown to be normally absent from FMRP-rich RNA granules but to be recruited into these granules upon translation activation (17) . Indeed, under basal (DMSO-treated) conditions, eIF4E was either absent or present at low levels in the RNA granules ( Fig. 3 D1 and D2) , indicative of RNA granules in a translationally dormant state. Blocking neuronal activity with TTX and APV for 2 hours, which induces local protein synthesis in neuronal dendrites (6) , increased the amount of eIF4E immunolabeling in FMRP-rich RNA granules ( Fig. 3 E1 and E2 ) (gold particles per granule: 2.5 Ϯ 0.65, n ϭ 10 for DMSO-treated group; 6.36 Ϯ 1.06, n ϭ 14 for TTX plus APV-treated group; P Ͻ 0.01), suggesting that dendritic RNA granules become translationally active upon activity blockade. We next performed double ImmunoGold labeling experiments with FMRP and GluR1 antibodies to directly examine GluR1 synthesis in FMRP-containing RNA granules. Under basal conditions or after DMSO treatment, a low background level of GluR1 proteins was present in these RNA granules (Fig. 4A ). Treating neurons with 1 M RA rapidly increased GluR1 protein level within 10 min (Fig. 4B) , and this elevated level of GluR1 in RNA granules persisted for at least 30 min (Fig. 4D) . Consistent with our previous findings that blocking neuronal activity promotes RA synthesis in neurons (8) , blocking neuronal activity with TTX and APV for 30 min also significantly increased GluR1 protein level in these RNA granules (Fig. 4C) , and the increase persisted for at least 2 h (Fig. 4E) . The slower time course of GluR1 accumulation in RNA granules after activity blockade in comparison with direct RA treatment likely reflects the time required for the production and local accumulation of RA triggered by reduced activity. A translation inhibitor, anisomycin, blocked the observed changes induced by activity blockade or RA, indicating that the increase in GluR1 protein level in RNA granules is due to local synthesis of GluR1 proteins (Fig. 4 D and E) . Presence of a transcriptional inhibitor, actinomycin D, did not affect the RA-induced increase. Consistent with our previous findings that GluR2 translation is not regulated by RA or activity blockade (8) , protein levels of GluR2 remained low and unchanged under all these conditions (Fig. 4 D and E) , although GluR2 mRNA has been found in neuronal dendrites (18) .
Activity Blockade or RA Treatment Induces the Presence of RAR␣ in
RNA Granules. Retinoid signaling is mediated by its nuclear receptors, the RARs and the RXRs, both of which consist of isotypes ␣, ␤, and ␥. RAR␣ is expressed at high levels in hippocampal CA1-CA3 pyramidal cells (11, 12) , RAR␤ is not expressed in hippocampus, and RAR␥ is primarily expressed in the dentate gyrus granule neurons (12) . Using biochemical methods, we have previously found that RAR␣ protein is present in synaptoneurosomes (8) . Immunocytochemistry of adult hippocampal slices further revealed its subcellular localization in neuronal dendrites (Fig.  5A) , indicative of a possible nonnuclear function of RAR␣.
It was suggested that RAR␣ is present at the neuronal cell surface, i.e., functions as a cell-surface receptor (13) . To test this possibility, we performed surface protein biotinylation in our cultured neurons. We did not detect any surface expressed RAR␣ under either basal (DMSO-treated) or RA-treated conditions (Fig.  5B ). Under these same experimental conditions, a significant increase in surface GluR1 expression induced by RA treatment was detected, which is consistent with our previous findings (8) and validates our experimental procedures. We next performed double ImmunoGold labeling of RAR␣ in cultured hippocampal neurons. Neurons in DMSO-treated cultures showed low-level diffuse labeling of RAR␣ protein in the dendrites (Fig. 5C Left) , without specific localization in RNA granules (Fig.  5C Right, E, and F) . Treatment with 1 M RA induced, within 5 min after the onset of treatment, a large increase in the RAR␣ protein level in FMRP-containing RNA granules (Fig. 5 D and F) . The same increase was observed upon TTX and APV treatment, albeit with a slower time course (Fig. 5E ). RAR␣ accumulation in the RNA granule is not transcription-or translation-dependent because it was not blocked by anisomycin or actinomycin D (Fig. 5 E  and F) , suggesting that RA and activity blockade causes either a rapid translocation of RAR␣ proteins into existing RNA granules or a rapid assembly of RNA granules containing RAR␣.
GluR1 and RAR␣ protein exhibited intriguingly different time courses with which they accumulated in the RNA granule upon RA treatment. The RAR␣ level peaked 5 min after RA treatment, whereas the GluR1 level increased with a highly reproducible 10-min delay (Figs. 4D and 5F ), suggesting that RAR␣ accumulates in RNA granules before the onset of GluR1 translation through a mechanism yet to be identified. In our previous study, we reported that RAR␣ is required for dendritic GluR1 synthesis-dependent homeostatic synaptic plasticity (8) . To determine whether dendritic RAR␣ is involved in local translation of GluR1 in RNA granules, we performed double ImmunoGold labeling of RAR␣ and GluR1 in neurons treated with TTX and APV for 2 h, which fully activates local translation of GluR1 (Fig. 6) . We found that these two proteins colocalized in all 25 RNA granules examined, suggesting a role for RAR␣ in GluR1 translation in RNA granules.
The RAR␣ protein level in the RNA granule declined rapidly after the 5-min peak under RA treatment (Fig. 5F ), and the same decline was also observed after 24 h of TTX and APV treatment (Fig. 5E) , in contrast to the sustained GluR1 levels. This observation suggests that RAR␣ may be required for the initial activation of GluR1 translation but is not required for maintaining the translationally active state of the RNA granule. Alternatively, it may represent a brief wave of translation in the RNA granule, which is turned off by a negative-feedback mechanism.
Discussion
The involvement of dendritic protein translation in synaptic plasticity is well documented (19) . Several molecular players have been suggested to play roles in homeostatic synaptic plasticity, including ␣/␤ CaMKII (20) , the immediate-early gene Arc/Arg 3.1 (21), TGF-␤ (22), and glia-derived TNF␣ (23) . However, none of those factors has been directly associated with the form of synaptic scaling that requires local translation of GluR1 in neuronal dendrites (5, 6) . Our recent findings (8) revealed that RA, whose synthesis can be regulated by neuronal activity, activates GluR1 synthesis under activity blockade and mediates synaptic scaling. Moreover, we demonstrated a critical involvement of RAR␣ in homeostatic plasticity. In the current study, we further explored the dynamic localization of RAR␣ in homeostatic plasticity at the ultrastructural level.
We made four major observations that shed light on the mechanism by which RA mediates synaptic scaling: (i) RA induced the local translation in neuronal dendrites of a GluR1-UTR reporter mRNA (Fig. 1); (ii) RA or activity-blockade induced rapid GluR1 synthesis in neuronal RNA granules (Fig. 4) , and the dendritic GluR1 synthesis activated by RA is independent of mTOR signaling (Fig. 2) ; (iii) The classical nuclear receptor RAR␣ is present in dendritic RNA granules, and its concentration in these granules is rapidly enhanced upon activity blockade or RA treatment (Fig. 5) ; (iv) RAR␣ is found in RNA granules that are undergoing active GluR1 synthesis (Fig. 6) ; and (v) The time courses with which RAR␣ and GluR1 appear in RNA granules upon RA treatment differ dramatically, with the former preceding the latter by Ͼ5 min.
Translational regulation in neurons is important for the expression and maintenance of long-term synaptic plasticity. The seminal discovery of polyribosomes in neuronal dendrites (16) pioneered the investigation of the functional significance and mechanism of regulated local protein synthesis in neuronal dendrites (19) . In addition, the organelles that constitute the secretory pathway, such as the endoplasmic reticulum (ER), the Golgi apparatus, and the trans-Golgi network, are present in dendrites (24); thus, not only cytoplasmic proteins but also integral membrane proteins (i.e., receptors and channels) can be synthesized locally in dendrites. Supporting this notion, mRNAs encoding synaptic proteins, including those that are integral membrane proteins, are sorted and trafficked into dendrites to be translated locally there (25) , a process made possible through packaging mRNAs into RNA granules. In addition to mRNAs, RNA granules also contain various ribosomal subunits, translation factors, decay enzymes, helicases, scaffold proteins, and RNA-binding proteins, which are involved in the localization, stability, and translation of their RNA cargo (14) . In the present study, we characterized neuronal RNA granules with ImmunoGold labeling and EM and found that local protein translation can indeed occur rapidly in RNA granules upon translation activation by activity blockade or direct RA treatment. In agreement with earlier observations, we have observed that translation activation recruits eIF4E into neuronal RNA granules (15, 17) . Upon RA treatment, we observed the appearance of newly synthesized GluR1 receptors as early as 10 min after the treatment. This rapid enhancement of GluR1 mRNA translation can be explained by an increase in the efficiency of translation initiation and/or by removal of inhibition during elongation (26) . The exact mechanism of RA/RAR␣-regulated translation activation remains to be determined. Recent studies indicate that some well characterized transcription factors, such as p53 tumor suppressor protein, may play a dual role as RNA-binding proteins (27) . This raises the intriguing possibility that, in a translational context, RAR␣ may bind directly to mRNAs. Moreover, it is unclear whether RAregulated protein synthesis is GluR1-specific or is a general mechanism for regulation of diverse local protein synthesis-dependent processes. Addressing these and related questions will be of great interest for understanding the entire range of RA signaling in the brain.
Experimental Procedures
Detailed experimental procedures are described in supporting information (SI) Experimental Procedures.
Cell Cultures. Primary hippocampal cultures were prepared from the brains of rats at embryonic day 22 and maintained in serum-free Neurobasal medium supplemented with B-27 and Glutamax (GIBCO-BRL) for 2 weeks in vitro (28) . Hippocampal slice cultures were prepared from 7-to 8-day-old rat pups (29) and maintained in Neurobasal-A medium supplemented with horse serum (HyClone), insulin (Sigma), and Glutamax. For details, see SI Experimental Procedures.
ImmunoGold EM. Cultured hippocampal neurons were fixed for ImmunoGold EM for 1 h by using 1% paraformaldehyde, 2.5% glutaraldehyde, 0.1% tannic acid, and 0.1% picric acid in PBS, followed by 1% tannic acid incubation on ice for 30 min and 1% uranyl acetate incubation at room temperature for 2 h. After dehydration in ascending concentrations of ethanol, fixed cells were infiltrated and embedded in LRwhite (Ted Pella). See SI Experimental Procedures for details on ImmunoGold labeling.
